Related Experiment Video
Updated: Dec 31, 2025
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
Total femur prosthesis in oncological and not oncological series. Survival and failures
Francesco Muratori1, Nicola Mondanelli2, Xhulio Prifti1
1Divisione di Ortopedia Oncologica e Ricostruttiva, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy.
Abstract:
Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.
